Supplemental data shows IGM-7354 enhances NK and CD8+ T cell cytotoxicity in PD-L1 positive tumors, suggesting potential for cancer therapy.
Supplemental Figure 3. IGM-7354 preferentially expands NK and CD8+ T cells in vitro.
No takes yet. Share an insight, caveat, or question.
Desbois et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: